MBChB MSc DPhil FFPH
Senior Clinical Research Fellow
Ben Lacey is an epidemiologist and public health physician. He is currently Senior Clinical Research Fellow at UK Biobank, based at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford; and Honorary Consultant in Public Health at Oxford University Hospitals NHS Trust.
His research uses large-scale epidemiological studies to understand the major causes of premature death and disability in different populations, with a particular focus on the effects of adiposity and other metabolic factors. He is currently working on cohort studies in the UK, Cuba, Malaysia and India. He is also interested in the use of routinely collected healthcare data (including linked electronic health records) to enhance such studies and, more generally, improve the measurement of population health.
He studied medicine at the University of Edinburgh and undertook specialist training in public health in Oxford, during which time he received an MSc in Global Health Science and a DPhil in Epidemiology. His previous funding has been through the National Institute for Health Research (NIHR), the British Heart Foundation (BHF), and the US Centers for Disease Control and Prevention (US CDC). He was made a Fellow of the Faculty of Public Health in 2012.
Social inequality, chronic disease and COVID-19: county-level analysis in the United States
Islam N. et al, (2020), Journal of Epidemiology and Community Health
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth GA. et al, (2020), Journal of the American College of Cardiology, 76, 2982 - 3021
Alcohol consumption and cause-specific mortality in Cuba: prospective study of 120 623 adults
Rojas NA. et al, (2020), EClinicalMedicine
Authors' Reply: Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries
Islam N. et al, (2020)
Five insights from the Global Burden of Disease Study 2019.
GBD 2019 Viewpoint Collaborators None., (2020), Lancet, 396, 1135 - 1159
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Demographics Collaborators None., (2020), Lancet, 396, 1160 - 1203
- Accurately estimating the burden of vascular disease using electronic health records
- Adiposity, body fat distribution and risk of chronic disease in Asian and European populations
- Adiposity, COVID-19 and other infections in UK Biobank
- Analysing big data from electronic health records to understand the determinants of cardiovascular disease
- Deep phenotyping of vascular events in large-scale epidemiological studies using electronic health records
- Understanding and modelling the geographical variation in relative risks for smoking and other major risk factors for burden of disease analyses